Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study(). (Q39444949)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study().	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study(). (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

expanded access

1 reference

based on heuristic

inferred from title

author name string

Ian R Judson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Charlotte Benson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Ofer Merimsky

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Daniela Katz

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Klaus W Freivogel

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Dara Stein

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Minesh Jobanputra

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Arron Mungul

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Stephanie C Manson

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Roberta Sanfilippo

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

19 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

56

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1769-1775

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

copyright license

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

19 July 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The epidemiology of sarcoma

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Pazopanib in the treatment of soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Pazopanib: Clinical development of a potent anti-angiogenic drug

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Pazopanib, a new therapy for metastatic soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Trabectedin in patients with metastatic soft tissue sarcoma: a retrospective single center analysis.

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Successful use of pazopanib for treatment of refractory metastatic hemangiopericytoma

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour.

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain.

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2017.1332779

21 January 2018

Identifiers

10.1080/0284186X.2017.1332779

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28723233%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39444949&oldid=1899153491"